Longevity TV

Startup Showcase: Rejuvenate Biomed: What do you think?

Rejuvenate Biomed are ready to take their first Longevity therapy into clinical trials: Invest, buy, or both? It's time to have your say on...

Exclusive video interview with Dave Asprey

We talk supplementation, neurotech, mitochondrial dysfunction, clinical scale-ups, COVID and CGM with Longevity legend: Dave Asprey Ahead of Revolution Against Aging and Death conference, which...

Startup Showcase: Jinfiniti: What do you think?

Comprehensive biomarker tech: Invest, buy, or both? It's time to have your say on Jinfiniti. We like what Jinfiniti are doing; but that's just our...

Exclusive video interview: David Wood demystifies the transhumanist agenda

As Longevity moves quickly into the mainstream there are terms and legacies that some use to challenge the sector's validity: we explore what it...

The Big Picture: Covid-19 and Longevity investing

Jim Mellon, Chairman and Founder, Burnbrae Group

Video interview: talking senescence with Nina Khera

Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. As we’ve covered in the past, Biotein’s Nina Khera has a mission...

Video interview with BioViva’s Liz Parrish

BioViva and Integrated Health Systems: How many patients in trials? Where are they located? What pipeline stage? As we've covered in the past, BioViva's Liz...

Video interview with Dr Isabelle Schiffer on senolytic safety

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation published its latest risk-benefit analysis, which explores the combined...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Exclusive video interview: Human Longevity Inc.’s Chairman

After $0.5bn cumulative investment, Human Longevity Inc. pivots into high-end medical services to seek scale and ROI. For a few years we tracked Human Longevity Inc.'s...

Latest articles

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Deliver us from aging – the Quicksilver method

Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods. The COVID-19 pandemic has caused an upturn in the supplements industry; from...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

OneSkin launches topical senetherapeutic skin treatment

Extending skinspan with non-invasive senetherapeutic proprietary peptide. OneSkin is a Longevity company on a mission to transform the way we think about skin. Today the...